|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
KRON | Dinsmore Christopher | Chief Scientific Officer | Jan 04 | Sale | 1.18 | 7,366 | 8,718 | 260,969 | Jan 05 06:30 PM |
KRON | Dinsmore Christopher | Chief Scientific Officer | Dec 12 | Sale | 1.30 | 10,032 | 13,092 | 268,335 | Dec 13 04:10 PM |
KRON | Dinsmore Christopher | Chief Scientific Officer | Jul 06 | Sale | 1.75 | 6,634 | 11,625 | 278,367 | Jul 07 04:08 PM |
KRON | Dinsmore Christopher | Chief Scientific Officer | Feb 24 | Sale | 1.74 | 6,291 | 10,918 | 285,001 | Feb 24 09:36 PM |
KRON | Dinsmore Christopher | Chief Scientific Officer | Dec 12 | Sale | 1.81 | 9,138 | 16,496 | 162,936 | Dec 14 04:31 PM |
KRON | Dinsmore Christopher | Chief Scientific Officer | Dec 13 | Sale | 12.37 | 11,386 | 140,845 | 84,974 | Dec 15 05:08 PM |
KRON | Dinsmore Christopher | Chief Scientific Officer | Oct 04 | Option Exercise | 3.27 | 9,189 | 30,048 | 105,549 | Oct 04 06:24 PM |
KRON | Dinsmore Christopher | Chief Scientific Officer | Oct 04 | Sale | 20.81 | 9,189 | 191,195 | 96,360 | Oct 04 06:24 PM |
KRON | Dinsmore Christopher | Chief Scientific Officer | Sep 07 | Option Exercise | 3.27 | 9,189 | 30,048 | 105,549 | Sep 09 01:23 PM |
KRON | Dinsmore Christopher | Chief Scientific Officer | Sep 07 | Sale | 21.91 | 9,189 | 201,302 | 96,360 | Sep 09 01:23 PM |
KRON | Dinsmore Christopher | Chief Scientific Officer | Aug 02 | Option Exercise | 3.27 | 9,189 | 30,048 | 105,549 | Aug 03 05:13 PM |
KRON | Dinsmore Christopher | Chief Scientific Officer | Aug 02 | Sale | 20.59 | 9,189 | 189,165 | 96,360 | Aug 03 05:13 PM |
KRON | Dinsmore Christopher | Chief Scientific Officer | Oct 14 | Buy | 19.00 | 5,250 | 99,750 | 5,250 | Oct 16 03:39 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite